Treatable Intellectual Disability

DHPR Deficiency (Biopterin Deficiency)

BIOCHEMICAL DEFECT

Stacks Image 274

DIAGNOSIS

Gene
QDPR (AR)

Diagnostic Test
CSF Neurotransmitters & Biopterin Loading Test

Stacks Image 275

SIGNS & SYMPTOMS

Neurological
Dystonia

Non-Neurological
- - -

Stacks Image 276

THERAPY

Treatment
BH4, Diet, Amine Replacement, Folinic Acid

Level of Evidence
4

Clinical Practice
Standard of Care

Treatment Effect
Improves psychomotor development/IQ & neurological manifestations



Stacks Image 277
DHPR Deficiency (Biopterin Deficiency)

DHPR Deficiency (Biopterin Deficiency)

Dihydropteridine reductase (DHPR) deficiency is a disorder of tetrahydrobiopterin metabolism. Tetrahydrobipterin plays a role as a cofactor in Phenylalanine, L-Dopa and Serotonin metabolism. Thus deficiencies are mostly associated with hyperphenylalaninemia, and deficiency of Dopamine and Serotonine. Unless diagnosed by newborn screening via high blood phenylalanine levels, patients develop neurological problems within the first year of life, including progressive developmental delay, seizures, microcephaly, and parkinsonian dystonia. Episodes of irritability, lethargy, poor temperature control and other vegetative dysfunctions are common in severe cases. Significant cerebral atrophy and calcifications have been particularly described in DHPR deficiency. DHPR deficiency should be suspected in all infants with a positive neonatal screening test for phenylketonuria, especially when hyperphenylalaninemia is moderate.

No information available from this source.

This disease is not (yet) listed on their website.